http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago
-
Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective
-
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
-
Covalon Announces Third Quarter Fiscal 2023 Results
-
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial Results
-
Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites
-
Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023
-
Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida
-
Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon
-
Breakthrough Solution for Fragile Skin: Covalon’s IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children’s Hospital and Epidermolysis Bullosa Center of Excellence
-
Covalon Announces Second Quarter Results for Fiscal 2023
-
Covalon Announces Conference Call to Discuss Second Quarter Fiscal 2023 Financial Results
-
Covalon, Leader in Compassionate Pediatric Infection Prevention Solutions, to Participate in Neonatal/Fetal Conference in Columbus, Ohio on May 17 - 19, 2023
-
Compassionate Care Solutions Provider Covalon Participating in the Canadian Vascular Access Association and World Congress on Vascular Access Joint Conference on April 26-28, 2023 in Toronto
-
Covalon Presents New CLABSI Conscious Series Webinar: Protecting CVADs from Gross Contamination
-
Leader in Compassionate Care Infection Prevention Solutions, Covalon, to Participate in the Synova NICU Leadership Forum 2023 in Tucson, Arizona from March 19 to 23, 2023
-
Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders
-
Covalon Welcomes Martin Goldfarb, O.C., to its Board of Directors
-
Covalon To Hold Annual and Special Meeting of Shareholders on Wednesday, March 8, 2023
-
Covalon Announces Improved First Quarter Fiscal 2023 Results
-
Infection Prevention Solutions Provider Covalon to Participate for the First Time in NEO - The Conference for Neonatology in Las Vegas, NV on February 22-24, 2023
-
Covalon Announces Conference Call to Discuss First Quarter Fiscal 2023 Financial Results
-
Covalon Announces Fourth Quarter and Year End Results for Fiscal 2022 and Highlights Company Transformation Changes
-
Covalon Announces Conference Call to Discuss Fourth Quarter and Year End Fiscal 2022 Financial Results
-
Covalon's SurgiClear Dressing Plays an Important Part in Preventing Surgical Wound Infections at Top Children's Hospital
-
Covalon Launches New "CLABSI Conscious" Campaign to Help Children Heal Without Infections
-
Closing Chronic Wounds with Collagen Powder: University of Michigan case study demonstrates the efficacy of ColActive Plus Powder in resolving non-healing wounds
-
Covalon to Participate in the American Nurses Credentialing Center Magnet Conference in Philadelphia
-
Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto
-
Covalon Announces Voting Results from Fiscal 2021 Annual and Special Meeting of Shareholders
-
Covalon Announces Second Quarter Fiscal 2020 Results
-
Amir Boloor Joins Covalon’s Board of Directors
-
Martin Goldfarb, O.C., Joins Covalon’s Board of Directors
-
Covalon Postpones Annual Meeting of Shareholders Due to COVID-19
-
Covalon Announces Conference Call to Discuss New CovaGuard Antimicrobial Technology
-
Covalon Clarifies Previous Press Release
-
Covalon Announces New Breakthrough Antimicrobial Technology Formulated to Kill The COVID-19 Virus
-
Covalon Announces First Quarter Fiscal 2020 Results
-
Covalon Announces Conference Call to Discuss First Quarter Financial Results
-
Covalon Announces Fiscal 2019 Year-End Results and Plans for Fiscal 2020
-
Covalon Announces Conference Call to Discuss Year-End and Fourth Quarter Financial Results
-
Covalon Announces Closing of Non-Brokered Private Placement
-
Covalon Announces Re-Pricing of Private Placement
-
Covalon Announces Third Quarter Fiscal 2019 Results
-
Covalon Announces Private Placement of Up To $6.3 Million
-
Covalon CEO Provides Corporate Update
-
Covalon’s Award-Winning MediClear PreOp Product Recognized as Innovative Solution to Help Hospitals Reduce Surgical Site Infections
-
Lazard Ltd Reports Third-Quarter and Nine-Month 2018 Results
-
Covalon Announces Conference Call to Discuss Q2 Financial Results
-
Automated Vital Signs Solutions from Welch Allyn Help Ensure Accurate Readings, Enable Early Detection in the Battle to Curb Hypertension across Canada

